Source: Annual Congress 2007 - Eicosanoids in inflammation: new findings
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Serhan (Boston, United States of America). Lipoxins and related anti-inflammatory eicosanoids. Annual Congress 2007 - Eicosanoids in inflammation: new findings

Member's Comments

No comment yet.

Related content which might interest you: Lipid mediators in severe asthma Source: Eur Respir Mon 2011; 51: 218-235 Year: 2011 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Local and systemic imbalance of pro- and antiinflammatory cytokines in COPD Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Role of anti-inflammatory treatments in complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Anti-inflammatory and cytoprotective actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Novel anti-inflammatory agents Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Imbalance of anti-inflammatory (resolving D1) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2014 – Airway biomarkers Year: 2014 The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Production of alpha-1 antitrypsin by pro- and anti-inflammatory macrophages Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Late-breaking abstract: Cycloxygenase- and lypoxigenase-dependent generation of omega-3 electrophilic fatty acid-derivatives with anti-inflammatory properties Source: Annual Congress 2011 - Lung cell biology Year: 2011 Proinflammatory cytokine production during exercise: role of antioxidants and monocytes Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002 A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation Source: Annual Congress 2008 - COPD Year: 2008 LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013